253 related articles for article (PubMed ID: 19350105)
1. Myocardial protection against reperfusion injury: the cGMP pathway.
Garcia-Dorado D; Agulló L; Sartorio CL; Ruiz-Meana M
Thromb Haemost; 2009 Apr; 101(4):635-42. PubMed ID: 19350105
[TBL] [Abstract][Full Text] [Related]
2. Orphan targets for reperfusion injury.
Inserte J; Barrabés JA; Hernando V; Garcia-Dorado D
Cardiovasc Res; 2009 Jul; 83(2):169-78. PubMed ID: 19351740
[TBL] [Abstract][Full Text] [Related]
3. Signalling pathways in ischaemic postconditioning.
Hausenloy DJ
Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
[TBL] [Abstract][Full Text] [Related]
4. cGMP/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusion.
Inserte J; Barba I; Poncelas-Nozal M; Hernando V; Agulló L; Ruiz-Meana M; Garcia-Dorado D
J Mol Cell Cardiol; 2011 May; 50(5):903-9. PubMed ID: 21362429
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury.
Abdallah Y; Gkatzoflia A; Pieper H; Zoga E; Walther S; Kasseckert S; Schäfer M; Schlüter KD; Piper HM; Schäfer C
Cardiovasc Res; 2005 Apr; 66(1):123-31. PubMed ID: 15769455
[TBL] [Abstract][Full Text] [Related]
6. The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism.
Inserte J; Garcia-Dorado D
Br J Pharmacol; 2015 Apr; 172(8):1996-2009. PubMed ID: 25297462
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
[TBL] [Abstract][Full Text] [Related]
8. Postconditioning: reduction of reperfusion-induced injury.
Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 2006 May; 70(2):200-11. PubMed ID: 16545349
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of cGMP signalling protects coronary endothelium against reperfusion-induced intercellular gap formation.
Kasseckert SA; Schäfer C; Kluger A; Gligorievski D; Tillmann J; Schlüter KD; Noll T; Sauer H; Piper HM; Abdallah Y
Cardiovasc Res; 2009 Jul; 83(2):381-7. PubMed ID: 19234300
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide/cGMP signalling mediates the cardioprotective action of adrenomedullin in reperfused myocardium.
Hamid SA; Totzeck M; Drexhage C; Thompson I; Fowkes RC; Rassaf T; Baxter GF
Basic Res Cardiol; 2010 Mar; 105(2):257-66. PubMed ID: 19714395
[TBL] [Abstract][Full Text] [Related]
11. Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues.
Garcia-Dorado D; Ruiz-Meana M; Piper HM
Cardiovasc Res; 2009 Jul; 83(2):165-8. PubMed ID: 19502282
[No Abstract] [Full Text] [Related]
12. Calcium-mediated cell death during myocardial reperfusion.
Garcia-Dorado D; Ruiz-Meana M; Inserte J; Rodriguez-Sinovas A; Piper HM
Cardiovasc Res; 2012 May; 94(2):168-80. PubMed ID: 22499772
[TBL] [Abstract][Full Text] [Related]
13. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs.
Padilla F; Garcia-Dorado D; Agulló L; Barrabés JA; Inserte J; Escalona N; Meyer M; Mirabet M; Pina P; Soler-Soler J
Cardiovasc Res; 2001 Aug; 51(3):592-600. PubMed ID: 11476750
[TBL] [Abstract][Full Text] [Related]
14. The first minutes of reperfusion: a window of opportunity for cardioprotection.
Piper HM; Abdallah Y; Schäfer C
Cardiovasc Res; 2004 Feb; 61(3):365-71. PubMed ID: 14962469
[TBL] [Abstract][Full Text] [Related]
15. cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway.
Park M; Sandner P; Krieg T
Basic Res Cardiol; 2018 May; 113(4):24. PubMed ID: 29766323
[TBL] [Abstract][Full Text] [Related]
16. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.
Burley DS; Ferdinandy P; Baxter GF
Br J Pharmacol; 2007 Nov; 152(6):855-69. PubMed ID: 17700722
[TBL] [Abstract][Full Text] [Related]
17. Myocardial protection: is primary PCI enough?
Hausenloy DJ; Yellon DM
Nat Clin Pract Cardiovasc Med; 2009 Jan; 6(1):12-3. PubMed ID: 18852713
[No Abstract] [Full Text] [Related]
18. Loss of cardioprotection with ageing.
Boengler K; Schulz R; Heusch G
Cardiovasc Res; 2009 Jul; 83(2):247-61. PubMed ID: 19176601
[TBL] [Abstract][Full Text] [Related]
19. Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.
Kasama S; Furuya M; Toyama T; Ichikawa S; Kurabayashi M
Eur Heart J; 2008 Jun; 29(12):1485-94. PubMed ID: 18490430
[TBL] [Abstract][Full Text] [Related]
20. Benefits of reperfusion beyond infarct size limitation.
Takemura G; Nakagawa M; Kanamori H; Minatoguchi S; Fujiwara H
Cardiovasc Res; 2009 Jul; 83(2):269-76. PubMed ID: 19176600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
